+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Exelon"

From
Global Alzheimer's Treatment Market Outlook 2027 - Product Thumbnail Image

Global Alzheimer's Treatment Market Outlook 2027

  • Report
  • June 2020
  • 163 Pages
  • Global
From
Alzheimer's Disease Market and Forecast Analysis 2034 - Product Thumbnail Image

Alzheimer's Disease Market and Forecast Analysis 2034

  • Drug Pipelines
  • February 2019
  • 300 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Exelon is a brand of drugs used to treat Alzheimer's Disease. It is a cholinesterase inhibitor, meaning it works by increasing the amount of a certain chemical in the brain that helps to reduce the symptoms of Alzheimer's. Exelon is available in both oral and patch forms, and is prescribed to treat mild to moderate Alzheimer's Disease. It is also used to treat dementia associated with Parkinson's Disease. Exelon is one of several drugs used to treat Alzheimer's Disease, and is one of the most commonly prescribed. Other drugs used to treat Alzheimer's Disease include Aricept, Namenda, and Razadyne. The Exelon market is highly competitive, with several major pharmaceutical companies competing for market share. Companies in the market include Novartis, Pfizer, Eisai, and Lundbeck. Show Less Read more